ELSEVIER
J. Lipid Mediators Cell Signalling 13 (1996) 331-332
Subject Index to Vol. 13 Acetyltmnsferase, 73 Actetylcholinesteras inhibitor, 207 Aggregation, 127 Airway hypermsponsiveness, 139 Airway wall thickening, 139 Alzheimer’s disease, 207 Anaphylaxis, 283 Antagonist, 249 Antigen, 223 Antiproteinases, 35 Arachidonic acid, 283 Arachidonic acid metabolism, 127 Arthritis, 35 Aspirin, 115 Atherosclerosis, 19 Autoimmunity, 283 Blood platelet, 127 Calcium, 63, 127, 151 Calcium influx, 163 Cbolesteryl sulfate, 127 cuz+, 19 cv-4151, 1 Cyclic AMP, 51 Cycle-oxygenase, 1I5 Cyclopiazonic acid, 163 Cytokines, 35
Essential fatty acid, 99, 115 Evening primrose oil, 99, 115 Fatty acid, 295 Fibroblast growth, 89 N-Formyl-methionyl-leucyl-pbenylalanine, filial cells, 5 1 Guinea pig, 139 Hepoxilin As, 63 Hepoxilin B,, 63 High-affinity antagonist, 249 High-density lipoprotein, 73 Host plant, 295 Human, 73 Human neutrophils, 63 Human umbilical vein endothelial cells, 19 12fSJ-Hydroxyeicosatetraenoic acid, 233 Hypocontractility, 177 Indomethacin, 177 Interferon-y, 89 Intracellular calcium, 163 Intracellular calcium stores, 163 Isbogrel, 1 Juniperis uirginiensis,
283
Jurkat, 151 Dexamethasone, 177 Diabetes mellitus, 99, 115 Diacylglycerol, 301 Diacylglycerols, 233 DNA synthesis, 233 Edema, 223 Eicosanoid, 283 Electromagnetic field, 301 Endothelial cells, 73
LDL oxidation, 19 Lipid, 295 Lipid peroxidation, 9, 19 Lipid second messenger, 301 Lipopolysaccharide. 177 Liver epithelial cells, 233 Low-density lipoprotein, 19 Lung macrophage, 89 Lysophosphatidic acid, 5 1
163
332 Membrane potential, 15 1 Mitsunobu reaction, 63 Modified LDL, 19 Molecular electrostatic potential, Muga silkworm, 295
Subject index Platelet activation, 127 Polymorphonuclear leukocytes, Protein kinase C, 5 1, 233
163
249
Nerve conduction, 99, 115 Neural transmission, 115 Neurokinin- 1, 223 Neuropathy, 99, 115 Nitric oxide, 9 PAF antagonist, 189, 207 PGDF, 89 PGI, production, 1 Phannacophore, 249 Phosphatidic acid, 301 Phosphatidylserine, 15 1 Phospholipase C, 51 Phospholipid, 15 1 Phospholipids, 233 Platelet-activating factor, 35, 73, 139, 163, 249
Rabbit platelets, 1 Rat aortic rings, 1 Renal ischaemia-repcrfusion, Sensitization, 51 Signaling phospholipase, 301 Skin, 223 SR 140333, 223 Streptozotocin, 99, 1 I5 Structure-activity relationship, Substance P, 223 Synthesis, 63
9
189, 207
T cell, 151 Tetmhydrofuran, 189, 207 Thiirano-hepoxilin A r, 63 Thromboxane A, receptor antagonist, TXA, synthase inhibition, 1
177